• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型氟喹诺酮类药物。

The newer fluoroquinolones.

机构信息

Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, 645 N. Michigan Avenue, Suite 900, Chicago, IL 60611, USA.

出版信息

Infect Dis Clin North Am. 2009 Dec;23(4):1027-51, x. doi: 10.1016/j.idc.2009.06.003.

DOI:10.1016/j.idc.2009.06.003
PMID:19909896
Abstract

Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones-ciprofloxacin, levofloxacin, and moxifloxacin.

摘要

临床医生因其良好的安全性和广泛的适应证而热衷于使用氟喹诺酮类药物。本文综述了氟喹诺酮类药物的药理学、药效学原则和氟喹诺酮类耐药机制,重点介绍了近年来革兰氏阴性菌和肺炎链球菌对氟喹诺酮类药物耐药的流行病学趋势。本文还讨论了氟喹诺酮类药物的重要安全性问题,并介绍了最常用的氟喹诺酮类药物——环丙沙星、左氧氟沙星和莫西沙星的适应证。

相似文献

1
The newer fluoroquinolones.新型氟喹诺酮类药物。
Infect Dis Clin North Am. 2009 Dec;23(4):1027-51, x. doi: 10.1016/j.idc.2009.06.003.
2
The newer fluoroquinolones.新型氟喹诺酮类药物。
Med Clin North Am. 2011 Jul;95(4):793-817, viii. doi: 10.1016/j.mcna.2011.03.006.
3
The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.莫西沙星及其他氟喹诺酮类药物在特殊患者群体中的安全性概况。
Curr Med Res Opin. 2007 Jun;23(6):1403-13. doi: 10.1185/030079907X188099. Epub 2007 May 8.
4
Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.化脓性链球菌emm6型中高水平氟喹诺酮耐药性的出现以及环丙沙星、左氧氟沙星和莫西沙星的体外耐药性选择。
J Antimicrob Chemother. 2009 May;63(5):886-94. doi: 10.1093/jac/dkp057. Epub 2009 Mar 11.
5
New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.新型氟喹诺酮类药物在下呼吸道感染中的应用及肺炎球菌耐药性的新趋势
Infection. 2005 Jun;33(3):106-14. doi: 10.1007/s15010-005-4102-8.
6
Fluoroquinolones in the management of community-acquired pneumonia in primary care.氟喹诺酮类药物在初级保健中治疗社区获得性肺炎的应用。
Expert Rev Anti Infect Ther. 2010 Nov;8(11):1259-71. doi: 10.1586/eri.10.110.
7
Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.氟喹诺酮类药物对金黄色葡萄球菌高水平耐苯唑西林的二项选择。
Int J Antimicrob Agents. 2010 Sep;36(3):216-21. doi: 10.1016/j.ijantimicag.2010.04.014. Epub 2010 Jul 14.
8
Will fluoroquinolones ever be recommended for common infections in children?氟喹诺酮类药物会被推荐用于儿童常见感染吗?
Pediatr Infect Dis J. 2007 Oct;26(10):865-7. doi: 10.1097/INF.0b013e3180cc20e4.
9
Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.铜绿假单胞菌引起医院感染的氟喹诺酮类耐药与左氧氟沙星而非环丙沙星的使用相关。
Int J Antimicrob Agents. 2010 Mar;35(3):261-4. doi: 10.1016/j.ijantimicag.2009.11.007. Epub 2009 Dec 31.
10
Fluoroquinolone antibiotics in infants and children.婴幼儿使用的氟喹诺酮类抗生素。
Infect Dis Clin North Am. 2005 Sep;19(3):617-28. doi: 10.1016/j.idc.2005.05.005.

引用本文的文献

1
Use of oral fluoroquinolones in France between 2014 and 2023: a nationwide drug utilization study.2014年至2023年法国口服氟喹诺酮类药物的使用情况:一项全国性药物利用研究。
JAC Antimicrob Resist. 2025 Aug 14;7(4):dlaf145. doi: 10.1093/jacamr/dlaf145. eCollection 2025 Aug.
2
Pharmacokinetic Equations Applied to Obtain New Topological Models in the Search of Antibacterial Compounds.应用药代动力学方程以获取用于寻找抗菌化合物的新拓扑模型。
Pharmaceuticals (Basel). 2025 Jun 10;18(6):865. doi: 10.3390/ph18060865.
3
Development of Hybrid Implantable Local Release Systems Based on PLGA Nanoparticles with Applications in Bone Diseases.
基于聚乳酸-羟基乙酸共聚物纳米颗粒的混合植入式局部释放系统的开发及其在骨疾病中的应用
Polymers (Basel). 2024 Oct 31;16(21):3064. doi: 10.3390/polym16213064.
4
Small RNA GadY in enhances conjugation system of IncP-1 by targeting SdiA.Small RNA GadY 在 IncP-1 中的增强子通过靶向 SdiA 作用于接合系统。
Front Cell Infect Microbiol. 2024 Jul 23;14:1445850. doi: 10.3389/fcimb.2024.1445850. eCollection 2024.
5
Mechanochemically Induced Solid-State Transformations of Levofloxacin.左氧氟沙星的机械力化学诱导固相转变
Mol Pharm. 2024 Jun 3;21(6):2838-2853. doi: 10.1021/acs.molpharmaceut.4c00008. Epub 2024 Apr 25.
6
Comparison of Ten Metal-Doped LaFeO Samples on Photocatalytic Degradation of Antibiotics in Water under Visible Light: Role of Surface Area and Aqueous Phosphate Ions.十种金属掺杂 LaFeO 样品在可见光下水中光催化降解抗生素的比较:比表面积和水相磷酸盐离子的作用。
Molecules. 2023 Apr 29;28(9):3807. doi: 10.3390/molecules28093807.
7
Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis.结核性脑膜炎患者脑脊液中氟喹诺酮类和碳青霉烯类药物的浓度
Front Pharmacol. 2022 Dec 12;13:1048653. doi: 10.3389/fphar.2022.1048653. eCollection 2022.
8
Ciprofloxacin induced toxic epidermal necrolysis with cholestatic hepatitis: A case report with literature review and revisit to the Naranjo adverse drug reaction probability scale.环丙沙星诱发中毒性表皮坏死松解症伴胆汁淤积性肝炎:一例报告并文献复习及重新审视纳兰霍药物不良反应概率量表
Clin Case Rep. 2022 Dec 20;10(12):e6766. doi: 10.1002/ccr3.6766. eCollection 2022 Dec.
9
Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with , , or : The Importance of the CLSI Breakpoints Revision.经验性氟喹诺酮类药物治疗感染、或患者的合理性:临床和实验室标准协会(CLSI)折点修订的重要性
Infect Drug Resist. 2021 Aug 31;14:3541-3552. doi: 10.2147/IDR.S329477. eCollection 2021.
10
High proportion of drug-resistant isolates in adult community-acquired pneumonia from Northeast India: A hospital-based study.印度东北部成人社区获得性肺炎中耐药菌株的高比例:一项基于医院的研究。
Lung India. 2021 Sep-Oct;38(5):460-465. doi: 10.4103/lungindia.lungindia_978_20.